This is not at all surprising, and it lends support for other combination therapies that have different mechanisms of action and targets. www.kireports.org/article/S246...
#NephSky #IgANephropathy #IgAN
Did you know that the โfour-hitโ hypothesis for IgA nephropathy #IgAN was first clearly articulated by Hitoshi Suzuki et al. in their 2011 J. Am. Soc. Nephrol. paper, โThe pathophysiology of IgA nephropathy.โ
#ISNWCN ๐ฏ๐ต #WCN26 ๐ฏ๐ต #WCN2026 ๐ฏ๐ต
#Nephpearls #NephSky
๐ pubmed.ncbi.nlm.nih.gov/21949093/
Therapeutic targets ๐ฏand positioning of treatments in IgA nephropathy ๐ฌ #IgAN ca. 2026 from @kidneyint.bsky.social
#ISNWCN ๐ฏ๐ต #WCN26 ๐ฏ๐ต #WCN2026 ๐ฏ๐ต
#Nephpearls #NephSky
๐ pubmed.ncbi.nlm.nih.gov/41895685/
Efficacy and Safety of Atrasentan in Patients with #IgAN Receiving Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2i) ca. 2026 from @asnpublications.bsky.social
#ISNWCN ๐ฏ๐ต #WCN26 ๐ฏ๐ต #WCN2026 ๐ฏ๐ต
#Nephpearls #NephSky
Photo Credit: @nephroseeker.medsky.social
๐ journals.lww.com/jasn/fulltex...
Trying to catch up with #IgAN trialsโ๏ธ
Check out ๐ โIgAN: An Overview of the Clinical Trialsโ ca. 2025 from @kidneymed.bsky.social @haresh11.bsky.social @alexgr23.bsky.social @saynanorouzi.bsky.social
#ISNWCN ๐ฏ๐ต #WCN26 ๐ฏ๐ต #WCN2026 ๐ฏ๐ต
#Nephpearls #NephSky
๐ pubmed.ncbi.nlm.nih.gov/41050133/
Pathogenesis of IgA Nephropathy #IgAN
#ISNWCN ๐ฏ๐ต #WCN26 ๐ฏ๐ต #WCN2026 ๐ฏ๐ต
#Nephpearls #NephSky
๐ pubmed.ncbi.nlm.nih.gov/37742867/
Pillars of IgA Nephropathy #IgAN Treatment
#ISNWCN ๐ฏ๐ต #WCN26 ๐ฏ๐ต #WCN2026 ๐ฏ๐ต
#Nephpearls #NephSky
๐๐ผ pubmed.ncbi.nlm.nih.gov/38398259/
I hope having my voice amplified by @ajkd.bsky.social will help clinicians and patients.
#IgANephropathy #IgAN #NephSky #MedSky
A little something I wrote about the patient perspective of disease: www.sciencedirect.com/science/auth...
#IgANephropathy #IgAN #NephSky #MedSky
Evidence from multicenter clinical studies and humanized mouse models indicates that glomerular mesangial IgA2 deposition contributes to the pathogenesis of IgA nephropathy
doi.org/10.1016/j.kint.2026.02.018
#MedSky #NephSky #IgAN @nu-nephrology.bsky.social
Commentary
The expanding role of complement inhibitors in the treatment of IgA nephropathy
doi.org/10.1016/j.kint.2025.12.015
Original article: doi.org/10.1016/j.kint.2025.11.017
#MedSky #NephSky #IgAN @ucm.es
The Batang Igan Bridge has officially opened, ending over 30 years of ferry service for residents. The bridge now cuts travel time from 30 minutes to just a few minutes.
Read more: sarawakdaily.com/batang-igan-...
#Mukah #Igan #Matu #Sarawak #Infrastructure #SarawakDaily #KuchingKing
Graphical abstract
Very cool
Enteric coated budesonide also reduces albuminuria, and GFR remains stable in #IgAN
Single arm prospective study from India in KI Reports
www.kireports.org/article/S246...
Check out our review "IgA Nephropathy #IgAN: An Overview of the Clinical Trials" #Nephmadness write up
#Nephpearls #NephSky
๐ pubmed.ncbi.nlm.nih.gov/41050133/
๐ NephMadness ajkdblog.org/2026/03/01/n...
Check out the KDIGOโ@medliveofficial.bsky.social CME program, โAdvancing Renal Protection in IgA Nephropathy,โ now available on demand.
Register and watch now: bit.ly/4aM5lW9
Learn the latest strategies to reduce proteinuria, slow eGFR decline, and improve long-term kidney outcomes in #IgAN.
Today is rare disease day! I made this infographic about my condition a while ago, but I wanted to share again today to help raise awareness ๐ #rarediseaseday #igan
Dose 2 of sibeprenlimab complete. Ask me anything.
#iganephropathy #igan #nephsky
Atrasentan is back: www.novartis.com/news/media-r...
ALIGN study: www.nejm.org/doi/full/10....
brand name โVanrafiaโ
#NephSky #IgAN
I am now going through another hospital's Transplant program.
Medical bills are piling up, so I'm resharing this information.
My sister is
@sassyscifichick.bsky.social
#Kidney #Transplant #IgANephropathy #CKD #Dialysis #GoFundMe #IgAN #Medical #Bills #Travel #Hospital #Doctors #KidneyTransplant
Currently doing N=1 test of COVID vs. sibeprenlimab, wish me luck.
#IgAN #IgANephropathy #NephSky
This cold has reached man-cold status. Spent all day sleeping off and on on the sofa. Hope it doesn't progress beyond this.
#IgAN #IgANephropathy #NephSky #sibeprenlimab
New York Presbyterian Rogosin Institute invites you to The Julie Lam & Kapil Mathur Education and Prevention Initiative IgAN Webinar "Understanding the Latest KDIGO Guidelines for IgA Nephropathy Care" presented by James Chevalier, MD Monday, March 2, 2026 at 7:00 PM Please register: https://cvent.me/EaEvoV
The Rogosin Institute invites you to their FREE Education and Prevention Initiative #IgAN Webinar โUnderstanding the Latest KDIGO Guidelines for IgA Nephropathy Careโ presented by James Chevalier, MD Monday, March 2, 2026 at 7:00 PM.
Please register: cvent.me/EaEvoV
BHV-1400 is exciting stuff.
#IgAN #IgANephropathy #NephSky
Now I get to see just how effective sibeprenlimab is since my high schooler politely gave me a cold over the weekend. Thankfully, it's not yet evolved to a man cold.
#IgAN #IgANephropathy #NephSky
Gerald Appel, MD from @columbiamed explains how the evolving #IgAN treatment landscape, in tandem with @gokdigo 2025 updated guidelines, has shifted management toward a more personalized approach.
Low-grade proteinuria, whether assessed at baseline or over time, is an important predictor of kidney disease progression in patients with IgA nephropathy #IgAN ca. 2026 from @asnpublications.bsky.social
#Nephpearls #NephSky
๐๐ผ pubmed.ncbi.nlm.nih.gov/41385286/